লোডিং...
Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases
Background: Atopic dermatitis (AD) is a chronic skin disease that affects 5-20% of children. This disease compromises the quality of life. Omalizumab offers a promising role in the treatment of severe atopic dermatitis.Objective: To share our experience with the use of omalizumab for treating severe...
সংরক্ষণ করুন:
| প্রকাশিত: | Revista Alergia México |
|---|---|
| প্রধান লেখক: | , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2019
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.redalyc.org/articulo.oa?id=486761439003 https://www.redalyc.org/journal/4867/486761439003/ https://www.redalyc.org/journal/4867/486761439003/html/ https://www.redalyc.org/journal/4867/486761439003/486761439003.epub https://www.redalyc.org/journal/4867/486761439003/movil |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|